Trial Profile
Tau PET Imaging in Atypical Dementias
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 22 Mar 2024
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Primary progressive aphasia
- Focus Diagnostic use
- 19 Mar 2024 Planned End Date changed from 1 Feb 2024 to 30 Mar 2024.
- 19 Mar 2024 Planned primary completion date changed from 1 Feb 2024 to 30 Mar 2024.
- 16 Apr 2022 Planned End Date changed from 1 Feb 2023 to 1 Feb 2024.